Biocon is a global biopharmaceutical company that believes everyone has the right to
affordable, high-quality medicines. Our four global businesses include generics,
biosimilars, research services, and novel biologics. From pipeline to production, and
from drug discovery to drug delivery, we bring differentiated, high-quality, and affordable
healthcare products to global communities.
Biocon Biologics is transforming patient outcomes by making life-changing therapies
more accessible to the world. Through affordable biosimilars, we are reducing the global
healthcare burden, increasing treatment options and driving innovation in biologics, to
advance health equity, globally.
Syngene is a contract research, development and manufacturing organization
(CRDMO) that provides integrated discovery, development, and manufacturing services
to pharmaceutical, biotechnology, animal healthcare, consumer goods and
agrochemical companies.
Syngene’s clients are world leaders in their fields, ranging from leading global
multinationals to small and medium-sized start-ups, non-profit institutions, academic
institutes and government organizations.